[1]https://www.gov.uk/drug-safety-update/febuxostat-updated-advice-for-the-treatment-of-patients-with-a-history-of-major-cardiovascular-disease [2]Saag KG, Becker MA, White WB, et al. Evaluation of Serum Urate Levels and the Clinical Manifestation of Gout with Cardiovascular Mortality from th...
MHRA Drug Safety Update — topical steroidsPeacock, DianeBritish Journal of General Practice
Drug Safety Update Yellow Card: Report a problem with a medicine or medical device Marketing authorisations and licensing guidance Product information about medicines Medical devices regulation and safety Latest information for patients MHRA guidance on coronavirus (COVID-19) ...
The article reports on a drug safety update from the British Medicines and Healthcare products Regulatory Agency (MHRA) which says that even if Prograf and Advagraf both contain tacrolimus they are not directly interchangeable because their formulations are differ. The update comes following reports ...
英国在对妊娠期间使用抗癫痫药物(包括普瑞巴林)的安全性进行审查后, 2021年1月在《药物安全更新》(Drug safety Update)中发布了新的安全建议,其中包括对患者的建议和一份公共评估报告。 在本文发表时注意到,由于数据相互矛盾,对普瑞巴林的潜在致畸风险还不能得出确切的结论。该综述是来自美国的一项队列研究,其中477名...
https://www.gov.uk/drug-safety-update/letters-and-medicine-recalls-sent-to-healthcare-professionals-in-august-2021 面向医疗专业人士的药物安全信息沟通(DHPC) https://assets.publishing.service.gov.uk/media/ Amiodarone DHPC_24_Aug_2021.pdf
Medicines and Healthcare products Regulatory Agency (UK). Live attenuated vaccines: avoid use in those who are clinically immunosuppressed. Internet Document : 18 Apr 2016. Available from: URL: https://www.gov.uk/drug-safety-update/live-attenuated-vaccines-avoid-use-in-those-who-are-clinically-...
Evaluating the communication within fire and rescue services and the NHS on the fire risk of emollients in accordance of the MHRA safety update The Medicines and Healthcare products Regulatory Agency update in 2018 reported 50 fatal fires linked with emollient use. It detailed the fire risk and ...
Assessing the safety, quality and efficacy of medicines, and authorising their sale or supply in the UK for human use Overseeing the UK Notified Bodies that audit medical device manufacturers Operating post-marketing surveillance and other systems for reporting, investigating and monitoring adverse react...
UK draft contingency legislation for drugand device regulation was laid in Parliament last week. MHRA intends to followthe same transitional periods as the EU for the application of MDR and IVDR inthe event of a no-deal scenario. ...